Latest dermatitis Stories
GENEVA, May 20, 2010 /PRNewswire/ -- - Expert Tips for Parents of Children With Eczema Several leading European dermatologists have today launched guidance to help parents reduce the burden of eczema on children living with this disease. Experts from Denmark, France, Germany, Poland and Spain have come together to agree a consensus of 'top tips', which focus on avoiding situations that trigger painful flares and different ways to increase eczema 'flare-free' periods. The 'top...
RALEIGH, N.C., March 9 /PRNewswire/ -- Arbor Pharmaceuticals ("Arbor"), a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has launched Pediaderm(TM) HC Complete Kit - an innovative new product for the comprehensive management of atopic dermatitis. Pediaderm HC Complete Kit contains Pediaderm HC (Hydrocortisone Lotion USP 2%) and patented Pediaderm Protective Emollient with Triple Synergy Technology(TM). Pediaderm HC Complete Kit...
Dermatologists can help identify allergens linked to this skin condition MIAMI, March 4 /PRNewswire-USNewswire/ -- Itchy irritated skin can leave some people scratching their heads trying to determine the cause of this bothersome condition. What did they touch? Is it just dry skin gone awry? Are they allergic to something in their home or workplace? The answers to these questions could require not only a little detective work, but the help of a dermatologist who can diagnose and treat the...
REHOVOT, Israel, and SAN DIEGO, California, March 3, 2010 /PRNewswire/ -- Foamix Ltd., (Foamix), a leading developer of topical foams for dermatological and gynecological use, and Therapeutics Inc. (TI), an innovative drug development company, announced today a joint venture that will focus on developing new prescription medicated foam formulations and demonstrating their safety and efficacy. The partnership will accelerate the development of value-added foam formulations for the...
LUND, Sweden, December 2 /PRNewswire/ -- DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - today announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization...
Health groups, nurses meet with Johnson & Johnson to discuss toxic ingredients SAN FRANCISCO, Sept. 22 /PRNewswire-USNewswire/ -- A peer-reviewed paper in the Journal of the Dermatology Nurses' Association raises fresh concerns that the chemical preservative used in America's leading baby shampoo may be causing increased rates of allergic contact dermatitis, an inflammation of the skin that varies from mild irritation to rashes and open sores. The paper states that quaternium 15, a...
CHICAGO, Aug. 3 /PRNewswire/ -- Known medically as atopic dermatitis (AD), eczema is characterized by dry, itchy skin and rashes.(1) Scratching the affected area of skin may result in redness, swelling, scaling, cracking, weeping of clear fluid, and crusting of the skin.(2) Immuno-modulators called topical calcineurin (cal-SEE-nur-in) inhibitors (TCIs) can be effective treatments for patients with mild, moderate or severe eczema(3) who fail to respond adequately to first-line prescription...
TOKYO, July 31 /PRNewswire/ -- R-Tech Ueno, Ltd. announced on July 29 after discussing its R&D policy at a meeting of the board of directors held on the day and determined the R&D items as follows. The company intends to actively strengthen R&D in the ophthalmologic & dermatological fields that are its priority and exclusive areas, and promote relevant affiliation, etc. with external entities. 1. Development code UF-021 (eye diseases) The item in question is isopropyl...
DOYLESTOWN, Pa., July 21 /PRNewswire/ -- Avidas Pharmaceuticals and LaRon Pharma Inc. today announced that they have entered into an agreement for LaRon to co-promote Avidas' key prescription-only convenience kits, Avidoxy(TM) DK defence kit and Scalacort(TM) DK defence kit. Under the terms of the agreement, LaRon will provide sales support focused on primary care and internal medicine physicians in the United States, while Avidas will continue its sales force specialty focus in...
TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. This double-blind, placebo-controlled study, conducted in Finland, included 13 patients with mild to moderate atopic dermatitis who applied the ProtoCure emulsion cream to the affected skin areas twice...
